CTI is a leading global full-service clinical research organization that specializes in therapeutic areas such as COVID-19, infectious diseases, and late-phase expanded access programs. With a strong commitment to quality and innovation, CTI collaborates with partners and healthcare organizations to develop effective treatment solutions for patients in need.
Through strategic partnerships and cutting-edge technology, CTI is at the forefront of medical progress, working on over 15 COVID-19 programs including global vaccine studies and treatment programs. Their expertise in complex immunocompromised patient populations and their dedication to community support make CTI a trusted and reliable partner in the fight against the impact of COVID-19.
Generated from the website